Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premier, Ohmeda and BOC in $2 billion agreement:

This article was originally published in Clinica

Executive Summary

Premier, the US' largest healthcare alliance, has formed a purchasing agreement with Ohmeda and BOC Gases, both part of UK-based BOC. The seven-year deal will result in sales of some $2.2 billion, BOC forecasts. The purchasing agreements will include anaesthesia delivery systems, respiratory gas monitors, suction and oxygen products, anaesthesia-related pharmaceuticals, infant care and other critical care products. Ohmeda is the sole source for most of the products covered.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT084534

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel